Clopidogrel Bisulphate 75mg + Aspirin 75mg | PETIVA-A 75

Clopidogrel Bisulphate 75 mg + Aspirin 75 mg is a dual antiplatelet therapy (DAPT) formulation used for the prevention of blood clot formation in patients at risk of cardiovascular events. This fixed-dose combination contains Clopidogrel 75 mg and Aspirin 75 mg, both of which work synergistically to reduce platelet aggregation and prevent thrombus formation.

Clopidogrel inhibits ADP-mediated platelet activation by selectively blocking the P2Y12 receptor, while Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), thereby reducing thromboxane A2 production. Together, they significantly reduce the risk of heart attack, stroke, and other atherothrombotic complications.

This combination is widely prescribed in patients with:

Acute Coronary Syndrome (ACS)

Post Percutaneous Coronary Intervention (PCI) with stent placement

History of myocardial infarction

Ischemic stroke

Peripheral arterial disease

It provides long-term cardiovascular protection when taken under medical supervision.